Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg" is generating significant coverage in the Business category, with 6 articles from 6 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Seeking Alpha, The Business Journals, Fierce Pharma and BioPharma Dive. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 82d ago.
Quick answers
Why is "Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg" trending?
Because 6 independent news sources published 6 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (6)
- Bristol Myers Squibb exits Cellares pact (BMY:NYSE) Seeking Alpha · 84d ago
- Fast-growing biotech startup Cellares plans layoffs after losing major customer The Business Journals · 84d ago
- Cellares CEO seeks to 'resize' company after loss of 'large' cell therapy manufacturing customer Fierce Pharma · 84d ago
- Cellares, a cell therapy manufacturing specialist, to lay off 100 employees BioPharma Dive · 84d ago
- Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters · 84d ago
- Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg Endpoints News · 84d ago
Topics
Related trends
How Maya Jama went from Bristol native to Celebrity Traitors star
Maya Jama garners widespread praise for a generous charity donation following a high-stakes betrayal in the finale of Celebrity Traitors.
Carson Hocevar, Ryan Blaney trade niceties a week after Bristol fight
Carson Hocevar and Ryan Blaney trade niceties following their widely covered Bristol Motor Speedway brawl.
NASCAR Cup Series Bristol lineup, TV schedule for Saturday's race
Joey Logano wins the NASCAR Cup Series Bass Pro Shops Night Race at Bristol Motor Speedway amid high drama.
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
Novartis and Bristol Myers Squibb halt autoimmune CAR-T trials following patient deaths, impacting the sector.
7 new dementia risk factors revealed
New medical guidance identifies seven additional risk factors for dementia, highlighting a significant gap in public awareness among adults over 40.
Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused
Novartis and Bristol Myers Squibb halt multiple CAR-T clinical trials for autoimmune diseases following patient deaths and safety reviews.